"Lymphoma, Non-Hodgkin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
MeSH Number(s)
C04.557.386.480
C15.604.515.569.480
C20.683.515.761.480
Concept/Terms
Lymphoma, Non-Hodgkin- Lymphoma, Non-Hodgkin
- Lymphoma, Non Hodgkin
- Lymphoma, Atypical Diffuse Small Lymphoid
- Lymphoma, Non-Hodgkin's
- Lymphoma, Non Hodgkin's
- Lymphoma, Non-Hodgkins
- Lymphoma, Non Hodgkins
- Non-Hodgkins Lymphoma
- Small Cleaved-Cell Lymphoma, Diffuse
- Small Cleaved Cell Lymphoma, Diffuse
- Lymphoma, Nonhodgkins
- Nonhodgkins Lymphoma
- Lymphoma, Small Cleaved Cell, Diffuse
- Lymphoma, Small Cleaved-Cell, Diffuse
- Non-Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Non-Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
- Diffuse Small Cleaved-Cell Lymphoma
- Diffuse Small Cleaved Cell Lymphoma
- Lymphoma, Nonhodgkin's
- Lymphoma, Nonhodgkin
- Nonhodgkin's Lymphoma
Lymphoma, High-Grade- Lymphoma, High-Grade
- High-Grade Lymphoma
- High-Grade Lymphomas
- Lymphoma, High Grade
- Lymphomas, High-Grade
Lymphoma, Intermediate-Grade- Lymphoma, Intermediate-Grade
- Intermediate-Grade Lymphoma
- Intermediate-Grade Lymphomas
- Lymphoma, Intermediate Grade
- Lymphomas, Intermediate-Grade
Reticulum-Cell Sarcoma- Reticulum-Cell Sarcoma
- Reticulum Cell Sarcoma
- Reticulum-Cell Sarcomas
- Sarcomas, Reticulum-Cell
- Sarcoma, Reticulum-Cell
- Sarcoma, Reticulum Cell
- Reticulosarcoma
- Reticulosarcomas
Lymphoma, Mixed-Cell- Lymphoma, Mixed-Cell
- Lymphoma, Mixed Cell
- Lymphoma, Mixed Lymphocytic-Histiocytic
- Lymphocytic-Histiocytic Lymphoma, Mixed
- Lymphocytic-Histiocytic Lymphomas, Mixed
- Lymphoma, Mixed Lymphocytic Histiocytic
- Lymphomas, Mixed Lymphocytic-Histiocytic
- Mixed Lymphocytic-Histiocytic Lymphoma
- Mixed Lymphocytic-Histiocytic Lymphomas
- Mixed-Cell Lymphoma
- Lymphomas, Mixed-Cell
- Mixed Cell Lymphoma
- Mixed-Cell Lymphomas
- Lymphoma, Mixed
- Lymphomas, Mixed
- Mixed Lymphoma
- Mixed Lymphomas
Lymphoma, Mixed-Cell, Diffuse- Lymphoma, Mixed-Cell, Diffuse
- Diffuse Mixed Small and Large Cell Lymphoma
- Diffuse Mixed-Cell Lymphoma
- Diffuse Mixed Cell Lymphoma
- Diffuse Mixed-Cell Lymphomas
- Lymphoma, Diffuse Mixed-Cell
- Lymphomas, Diffuse Mixed-Cell
- Mixed-Cell Lymphomas, Diffuse
- Mixed-Cell Lymphoma, Diffuse
- Mixed Cell Lymphoma, Diffuse
- Lymphoma, Mixed Cell, Diffuse
- Lymphoma, Small and Large Cleaved-Cell, Diffuse
- Mixed Small and Large Cell Lymphoma, Diffuse
- Lymphoma, Mixed Small and Large Cell, Diffuse
- Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Lymphoma, Small Noncleaved-Cell- Lymphoma, Small Noncleaved-Cell
- Lymphoma, Small Noncleaved Cell
- Diffuse Undifferentiated Lymphoma
- Diffuse Undifferentiated Lymphomas
- Lymphoma, Diffuse Undifferentiated
- Lymphomas, Diffuse Undifferentiated
- Undifferentiated Lymphoma, Diffuse
- Undifferentiated Lymphomas, Diffuse
- Lymphoma, Undifferentiated, Diffuse
- Small Non-Cleaved-Cell Lymphoma
- Small Non Cleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphoma
- Lymphomas, Small Noncleaved-Cell
- Noncleaved-Cell Lymphoma, Small
- Noncleaved-Cell Lymphomas, Small
- Small Noncleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphomas
- Lymphoma, Small Non-Cleaved-Cell
- Lymphoma, Small Non Cleaved Cell
- Lymphomas, Small Non-Cleaved-Cell
- Non-Cleaved-Cell Lymphoma, Small
- Non-Cleaved-Cell Lymphomas, Small
- Small Non-Cleaved-Cell Lymphomas
Lymphoma, Undifferentiated- Lymphoma, Undifferentiated
- Undifferentiated Lymphoma
- Lymphomas, Undifferentiated
- Undifferentiated Lymphomas
- Lymphoma, Pleomorphic
- Lymphomas, Pleomorphic
- Pleomorphic Lymphoma
- Pleomorphic Lymphomas
Lymphoma, Diffuse- Lymphoma, Diffuse
- Diffuse Lymphoma
- Diffuse Lymphomas
- Lymphomas, Diffuse
- Lymphosarcoma
- Lymphosarcomas
- Sarcoma, Lymphatic
- Lymphatic Sarcoma
- Lymphatic Sarcomas
- Sarcomas, Lymphatic
Lymphoma, Low-Grade- Lymphoma, Low-Grade
- Low-Grade Lymphoma
- Low-Grade Lymphomas
- Lymphoma, Low Grade
- Lymphomas, Low-Grade
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Non-Hodgkin".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Non-Hodgkin".
This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 25 | 6 | 31 |
1995 | 20 | 2 | 22 |
1996 | 14 | 2 | 16 |
1997 | 16 | 5 | 21 |
1998 | 16 | 0 | 16 |
1999 | 21 | 6 | 27 |
2000 | 14 | 2 | 16 |
2001 | 17 | 3 | 20 |
2002 | 11 | 7 | 18 |
2003 | 7 | 2 | 9 |
2004 | 13 | 1 | 14 |
2005 | 21 | 2 | 23 |
2006 | 19 | 4 | 23 |
2007 | 22 | 5 | 27 |
2008 | 24 | 10 | 34 |
2009 | 15 | 6 | 21 |
2010 | 24 | 9 | 33 |
2011 | 12 | 2 | 14 |
2012 | 21 | 5 | 26 |
2013 | 21 | 4 | 25 |
2014 | 19 | 2 | 21 |
2015 | 13 | 5 | 18 |
2016 | 10 | 2 | 12 |
2017 | 16 | 3 | 19 |
2018 | 19 | 4 | 23 |
2019 | 18 | 1 | 19 |
2020 | 24 | 2 | 26 |
2021 | 22 | 0 | 22 |
2022 | 16 | 0 | 16 |
2023 | 8 | 0 | 8 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.
-
Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease. EBioMedicine. 2024 Mar; 101:105033.
-
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood Adv. 2024 02 13; 8(3):736-745.
-
DLBCL arising from indolent lymphomas: How are they different? Semin Hematol. 2023 Nov; 60(5):277-284.
-
Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90. Blood Adv. 2023 11 14; 7(21):6665-6667.
-
Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging. Blood Adv. 2023 08 22; 7(16):4633-4646.
-
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. Leuk Lymphoma. 2023 09; 64(9):1583-1587.
-
Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities. JCO Glob Oncol. 2023 Jun; 9:e2200203.
-
Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines. PLoS One. 2023; 18(3):e0283186.
-
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities. Blood Cancer Discov. 2023 03 01; 4(2):150-169.
-
Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: an open label phase II study. Leuk Lymphoma. 2023 03; 64(3):738-741.